A Tumor Microenvironment-Based Multiomics Analysis for Predi

Toronto, ON (PRWEB) December 05, 2022 -- In immuno-oncology, biomarkers are widely used to guide clinical trial programs, help researchers better understand

Related Keywords

United Kingdom , Mike Mattie , Vera Kovacevic , Gilead Company , Honeycomb Worldwide Inc , Translational Sciences , External Collaborations , Senior Vice President , Scientific Executive Director , Tumor Microenvironment Based Multiomics Analysis , Life Science , Press Release ,